Who
Harry Penner Jr.
Director
Company insider
Files Form 4 as: Director, Celldex Therapeutics; Director, Altus Pharmaceuticals.
In numbers
- Trades disclosed
- 40
- Buys
- 1
- Sells
- 1
- Bought
- $10K
- Sold
- $434K
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 3 Apr 2006
- Last trade
- 25 Jun 2026
- Last filed
- 29 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Jun 2026filed 29 Jun 2026 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —26,000 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —26,000 at $0.00 | filing |
| 5 Jun 2025filed 9 Jun 2025 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —16,500 at $0.00 | filing |
| 13 Jun 2024filed 17 Jun 2024 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —16,500 at $0.00 | filing |
| 15 Jun 2023filed 20 Jun 2023 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —11,300 at $0.00 | filing |
| 16 Jun 2022filed 17 Jun 2022 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —13,600 at $0.00 | filing |
| 17 Jun 2021filed 21 Jun 2021 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 18 Jun 2020filed 19 Jun 2020 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —11,000 at $0.00 | filing |
| 19 Jun 2019filed 20 Jun 2019 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —4,500 at $0.00 | filing |
| 13 Jun 2018filed 15 Jun 2018 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —67,000 at $0.00 | filing |
| 15 Jun 2017filed 16 Jun 2017 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Code A | —10,000 | filing |
| 15 Jun 2017filed 16 Jun 2017 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 8 Jun 2016filed 9 Jun 2016 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Code A | —10,000 | filing |
| 8 Jun 2016filed 9 Jun 2016 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 10 Jun 2015filed 11 Jun 2015 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Code A | —6,500 | filing |
| 10 Jun 2015filed 11 Jun 2015 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —10,300 at $0.00 | filing |
| 4 Jun 2014filed 5 Jun 2014 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Code A | —2,000 | filing |
| 4 Jun 2014filed 5 Jun 2014 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —2,000 at $0.00 | filing |
| 6 Dec 2013filed 10 Dec 2013 | CLDX Celldex Therapeuticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —17,728 at $0.00 | filing |
| 6 Dec 2013filed 10 Dec 2013 | CLDX Celldex TherapeuticsDiagnostics & Labs | SEC FORM 4 Code M | $145K17,728 at $8.16 | filing |
News
No headline names them, or the companies they trade most, lately.